Find My Broker

BioNTech, or Biopharmaceutical New Technologies, is one of the leading pharmaceutical companies that are developing and manufacturing active immunotherapies for treating a variety of diseases. BioNTech stock price particularly started surging in late March 2021, followed by another extreme price jump in mid-July. This second surge took it to an all-time high at $390 on August 6th.

In this guide, we look at how to invest in BioNTech stock and make it as simple as possible for everyone interested in investing.

Sort By

1 Provider that match your filters

Payment methods


Customer service


1or more

Mobile App

1or more

Fixed commissions per operation

$1or more

Account Fee

$1or more


Total Fees (for 12 months)
What we like
  • Buy shares and ETFs with 0% commission
  • Social and copy trading network
  • Invest and trade crypto with low fees
Fixed commissions per operation
Account Fee
Mobile App
Cfds Copy Portfolio Etfs Funds Krypto Robo Advisor Stocks
Payment methods
Credit Card Neteller Skrill
Total Fees (for 12 months)

68% of retail investor accounts lose money when trading CFDs with this provider.

Account Info

Account From
Deposit fees
Inactivity fees
$10/month after 12 months
Operating margin
Minimum operation
CFD Position
Trading fees
Withdrawal fees

Fees per operation

Copy Portfolio
CFD Position
Savings Plan
Robo Advisor

How to Invest in BioNTech Stock?

If you only wish for us to provide quick instructions on how to invest in BioNTech stocks then we show you how to do so in the steps below.

  • Create Your Account — Start by creating a trading account on your chosen platform and complete the sign-up process.
  • Verify Your ID — Next, verify your ID by providing your driver’s license, passport, or ID.
  • Deposit Funds — Deposit funds that you will use as your initial investment through one of the numerous supported payment methods.
  • Invest in BioNTech Stock — Finally, search for BioNTech stock on your platform’s search bar and confirm your purchase.

Step 1 — Choose a Stock Broker

If you wish to invest in BioNTech stocks, the first step you need to make is to invest with your preferred broker. Of course, there are plenty of brokers available, so choosing the right one can be a challenge. In this section, we review some of the popular brokers that allow you to invest in BioNTech stock.

1. eToro

eToro is a popular stock broker with more than 26 million individual users. The platform offers high levels of security, and it is well-known for being safe, reliable, and fully licensed and regulated by multiple regulatory bodies. Some of them include CySEC, FINRA, UK FCA, and ASIC, among others.

eToro’s platform offers more than 2,500 investments instrument, and it is entirely commission-free. It is also well-known for its social trading feature, which allows users to copy others and gain insight from professional traders, thus learning as they go and still trading in assets the way.

Finally, the company also offers a CopyPortfolio feature, which is a simple way to invest in entire pre-prepared portfolios. The platform also allows users to begin investing with just $10.

Stock Broker Minimum Deposit Fractional Shares? Pricing System Cost of Buying Stocks Fees & Charges
eToro $10 Yes – $10 minimum 0% commission on ALL real stocks, spreads for CFDs Market spread is not included when purchasing real stocks No Deposit fees, $5 withdrawal fee, $10 inactivity fee, no account management fees.

Your capital is at risk. Other fees apply. For more information, visit 

Step 2 — Research BioNTech Stock

Users may want to do their research before investing, stock trades, or anything. Most assets can be unpredictable and volatile, so learning about the company will give you a more in-depth view of the fundamentals and history of your potential investment.

What is BioNTech?

The first thing to do before you make your investment decision is to research who and what the company is, in the first place. As mentioned earlier, the firm has seen a rapid price surge as it worked on developing a COVID-19 vaccine, which is no coincidence, as the world is desperate to shake off the pandemic that has been plaguing it for over a year and a half now.

BioNTech Stock Price

BioNTech stock has been listed on Nasdaq for the last two years, since October 11th, 2019. In that time, the stock price has had its ups and downs, but by looking at its overall price-performance — it has constantly been on the rise.

Its harshest drop was seen between September 17th and October 1st of 2021, although it is worth noting that it came after a particularly sudden rally that took it from $217 on July 9th to its current all-time high at $447, which it reached on August 9th. In a single month, the company more than doubled the value of its stock.

Currently, the stock is sitting at exactly $250 as of October 15th, 2021.

BioNTech Fundamentals

BioNTech reported that 2020 was a rather transformational year for the company, with the development and approval of the first mRNA drug in history. As of March 2021, the company delivered over 200 million doses of its Pfizer-BioNTech vaccine to over 65 countries

The company also saw a massive increase in revenue in the final quarter of 2020, earning an estimated €345.4 million. To put this into perspective, the firm earned only $28 million during the last quarter of 2019. Total revenue for 2019 was €108.6 million, while in 2020, that figure exceeded €482.3 million.

The increase in total revenue came due to two collaboration agreements for developing a COVID-19 vaccine, which ultimately led to the recognition of COVID-19 vaccine commercial revenues.

In the first quarter of 2021, the company recorded sales of €2.05 billion, with more than half of the amount flowing to its bottom line.

BioNTech Dividends

Dividend stocks are often pursued by investors as they provide passive income, allowing investors to earn without having to do anything but purchase and own stocks for a prolonged period of time.

However, when it comes to BioNTech, the company actually had a shareholder meeting during which its CFO, Sierk Poetting, disclosed that the management board and supervisory board will evaluate the possibility of proposing the initiation of a dividend next year.

BioNTech ESG Breakdown

When institutional investors go for a company, they typically research every aspect of it, including the ESG rating of the firm.

Earlier this year, BioNTech was awarded a “Prime” rating in its very first ESG rating, by the rating agency ISS ESG. As such, the company actually managed to enter a list of the top 10% of all rated companies in the Biotechnology and Pharmaceutical sector.

BioNTech Covid-19 Vaccine

Back in 2020, under the healthcare threat of COVID-19, BioNTech announced that it will be partnering with Pfizer (PFE) for developing the vaccine for the prevention of the coronavirus. While many know this vaccine as “the Pfizer vaccine,” and BioNTech is usually completely left out, the company’s contribution is very large. Together, the two firms created a vaccine that offers a 95% efficiency in preventing infectious disease, and this level of protection is confirmed at least 7 days after the second dose is received.

This very vaccine was also the first mRNA vaccine ever to be authorized in the UK. Only days later, it was approved in the United States, as well as Canada and Switzerland, with other countries soon to follow.

The vaccine’s official name is BNT162b2, it requires 2 shots that are 21 days apart, and it is recommended that moderately to severely immunocompromised people receive the 3rd dose, at least 28 days after the second one. Others can also receive the booster dose, although it is recommended that they wait at least six months following the 2nd shot.

Step 3: Open Account & Invest

Now that you know everything you need to know about BioNTech stock, you can analyse the information and make a decision on whether or not you wish to invest in the industry.

Should you choose to do so, you may want to pick a suitable brokerage that will cater to your investing needs. In the sections below, we will show you how to begin trading with the chosen broker of your choice. 

Step 1: Open Your Trading Account

Head over to the homepage of your chosen broker and begin the account set-up process. You will be required to fill in your personal details – including your full name, email address and mobile number. Create a username and password for the platform to continue.

Step 2: Verify Your Identity

Most popular brokers are regulated – which is why users may be required to verify their accounts. To do this, simply upload proof of ID (a copy of your driver’s license or passport) and proof of address (a copy of a bank statement or utility bill). Once these documents have been uploaded, your broker should verify them in a couple of minutes.

Step 3: Deposit funds

The next step is to deposit funds into your trading account. Most brokers may support 1 or more of the following payment methods:

  • Credit card
  • Debit card
  • Bank transfer
  • e-wallet

Choose your preferred payment option and deposit the funds into your account.

Step 4: Invest in BioNTech Stock

Once your account has been funded, proceed to search for BioNTech stock by searching on your platform’s search bar. Fill in the amount you want to credit into the trade, and confirm your transaction. 


In this guide, we have reviewed the BioNTech stock by reviewing the company’s fundamentals, stock price and more. Users can analyse all this information to make a proper assessment on whether or not to invest in BioNTech stock.

Should you choose to invest, you may want to do so by evaluating and choosing a suitable broker that can cater to your trading needs.


What is BioNTech?

BioNTech is a German biotechnology firm that develops and manufactures immunological therapies for patient-specific approaches to the treatment of diseases. It is also a company that collaborated with Pfizer on the creation of the vaccine known as BNT162b2.

Who owns BioNTech?

BioNTech owners are predominantly mutual funds and other institutional stakeholders, with even the largest shareholder owning less than 1% of the company.

Where is BioNTech based?

BioNTech is based in Mainz, Germany, although it also has research locations in San Diego and Cambridge, while it also owns production facilities in Idar-Oberstein, Martinsried, Neuried, and Berlin.

How much is BioNTech stock?

At the time of writing (October 15th), the company’s stock is valued at $250.33.



Ali Raza

Ali Raza

Ali is an experienced writer covering the cryptocurrency markets and the blockchain industry. He has 8 years of experience writing about cryptocurrencies, technology, and trading. His work can be found in various high-profiled investment sites including CCN,, BeInCrypto, Bitcoinist, and NewsBTC.